Loading...
XSTOORTI A
Market cap2mUSD
Dec 23, Last price  
3.50SEK
1D
-1.13%
1Q
2.34%
Jan 2017
29.68%
Name

Ortivus AB

Chart & Performance

D1W1MN
XSTO:ORTI A chart
P/E
—
P/S
0.72
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
7.30%
Rev. gr., 5y
10.00%
Revenues
84m
-19.55%
140,808,000173,550,000199,776,000162,408,00083,113,000105,039,00047,726,00045,748,00060,710,00036,105,00069,366,00072,619,00074,279,00058,799,00052,200,00050,848,000107,582,00094,272,000104,509,00084,081,000
Net income
-18m
L
12,995,000-17,713,000-149,186,000-61,289,000-68,946,000-18,480,000-22,271,000-37,860,0002,220,000-14,043,0001,400,000-7,090,000-7,079,000-11,605,000-13,391,000-16,580,00011,332,0009,211,0005,892,000-18,245,000
CFO
-303k
L-95.59%
55,569,000-18,161,000-40,418,000-1,396,000-18,976,000-10,052,000-26,694,000-8,688,0008,946,000-7,128,00031,934,000-3,387,0004,935,000-11,898,000-510,000-3,510,00018,630,0007,774,000-6,878,000-303,000

Profile

Ortivus AB (publ) develops and commercializes medical technology solutions for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitors and measures the patient's vital parameters, such as ECG, blood pressure, and SpO2; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed Life, which is designed for advanced monitoring and resuscitation; and MobiMed Cloud that supports multiplatform data sharing on Windows, Webb, IOS, and Android. It also provides support, implementation, training, and consulting services. The company was incorporated in 1985 and is headquartered in Danderyd, Sweden.
URL
https://www.ortivus.com/
IPO date
Jan 02, 1997
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
84,081
-19.55%
104,509
10.86%
94,272
-12.37%
Cost of revenue
100,479
97,849
81,705
Unusual Expense (Income)
NOPBT
(16,398)
6,660
12,567
NOPBT Margin
6.37%
13.33%
Operating Taxes
55
(79)
160
Tax Rate
1.27%
NOPAT
(16,453)
6,739
12,407
Net income
(18,245)
-409.66%
5,892
-36.03%
9,211
-18.72%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,907
2,056
1,269
Long-term debt
9,055
10,384
5,351
Deferred revenue
8,545
6,909
10,049
Other long-term liabilities
1,055
6,909
10,049
Net debt
5,673
4,843
(15,492)
Cash flow
Cash from operating activities
(303)
(6,878)
7,774
CAPEX
(423)
(6,093)
(6,702)
Cash from investing activities
(14,762)
(6,149)
(6,702)
Cash from financing activities
8,726
(1,490)
(1,240)
FCF
4,820
(10,125)
6,355
Balance
Cash
1,289
7,597
22,112
Long term investments
4,000
Excess cash
1,085
2,372
17,398
Stockholders' equity
(15,482)
2,648
(3,343)
Invested Capital
47,868
53,101
56,195
ROIC
12.33%
27.57%
ROCE
13.71%
29.36%
EV
Common stock shares outstanding
44,307
44,307
44,307
Price
4.74
-14.13%
5.52
6.15%
5.20
0.97%
Market cap
210,017
-14.13%
244,577
6.15%
230,399
0.97%
EV
215,690
249,420
214,907
EBITDA
(13,282)
9,168
15,905
EV/EBITDA
27.21
13.51
Interest
578
11
160
Interest/NOPBT
0.17%
1.27%